Clinical Trials · NCT05761431
A Single-dose Study of Octreotide Injection in Healthy Adult Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Enrollment
- 56
- Start date
- Mar 2023
- Locations
- 1 site, China
- Primary endpoint
- Incidence and severity of adverse events